Clinical trials
Terminated Breast Neoplasms trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 3 |
| Novartis Pharmaceuticals | 3 |
| Pfizer | 3 |
| GlaxoSmithKline | 2 |
| Intarcia Therapeutics | 2 |
| Sanofi | 2 |
| Alpha Tau Medical LTD. | 1 |
| Amgen | 1 |
| Antisoma Research | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 27 |
| Neoplasms | 4 |
| Carcinoma, Ductal, Breast | 2 |
| Carcinoma, Lobular | 2 |
| Carcinoma, Ovarian Epithelial | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms, Hormone-Dependent | 2 |
| Recurrence | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Breast Neoplasms, Male | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.